Table 3 Characteristics of the control patients and cardiac and plasma levels of succinate
From: Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
Study characteristics | |
|---|---|
Number patients, n | 15 |
Control | 6 |
Cardiac | 9 |
Median age, years | 62 ± 2.7* |
Pathological condition | Number of patients |
Coronary artery disease, n | 5 |
Acute myocardial infarction, n | 3 |
Coronary artery disease + Acute myocardial infarction, n | 1 |
Total | 9 |
Median blood levels NT-pro-BNP (pg/mL) | Â |
Coronary artery disease | 8101 ± 4524* |
Acute myocardial infarction | 171 ± 101* |
Coronary artery disease + Acute myocardial infarction | 25000 |
Median blood levels succinate (mmol/L) | Â |
Coronary artery disease | 0.9 ± 0.1* |
Acute myocardial infarction | 1 ± 0.2* |
Coronary artery disease + Acute myocardial infarction | 2.69 |